Supplementary Figure S22 from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.

Gabriele Todisco; Maria Creignou; Elsa Bernard; Ann-Charlotte Björklund; Pedro Luís Moura; Bianca Tesi; Teresa Mortera‐Blanco; Birgitta Sander; Monika Jansson; Gunilla Walldin; Indira Barbosa; Susanne E. Reinsbach; Isabel Juliana Hofman; Christer Nilsson; Tetsuichi Yoshizato; Marios Dimitriou; David Chang; Svanhildur Olafsdottir; Sigita Venckute Larsson; Magnus Tobiasson; Luca Malcovati; Petter Woll; Sten Eirik W. Jacobsen; Elli Papaemmanuil; Eva Hellström‐Lindberg

doi:10.1158/1078-0432.27033748.v1

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Transcriptomic impact on SF3B1 mutant MDS and low blasts outcome. Overall survival (OS) and Event Free Survival (EFS) stratified by transcriptomic classification (A-B) and estimated MEP percentage (C-D), respectively, in SF3B1 mutant MDS and low blasts, as defined according to ICC and WHO 2022 classification.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Todisco et al. (2024) studied this question.

synapsesocial.com/papers/68e58589b6db64358752282a https://doi.org/10.1158/1078-0432.27033748.v1

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S22 from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.

Ask about this paper

Abstract

Discussion

Cite This Study

Supplementary Figure S22 from Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading